The amount of online data and transactions are growing exponentially. Related is the increasing possibility of cyberattacks — one way to address these is by regulating parts of the internet.
Academic rigour, journalistic flair
Articles on Coronavirus
Displaying 821 - 840 of 5486 articles
Post-pandemic, the world of work will probably never be the same again. And that’s probably a good thing. We now have an opportunity to make it better.
Infections have been reported in people vaccinated with the Sinopharm vaccine, but these aren’t necessarily unexpected.
We recently heard reports of a new and dangerous ‘hybrid’ variant circulating in Vietnam. There is such as a thing as a hybrid viral variant — but this doesn’t appear to be it.
A large proportion of scientific research on coronaviruses is carried out in countries with no oversight of experiments designed to make pathogens more deadly.
If we think about the success of the UK’s vaccine rollout to date, and factor in how social norms tend to diffuse, then there’s good reason to be optimistic.
It is unlikely that we will reach full herd immunity for COVID-19. However, we are likely to reach a practical kind of herd immunity through vaccination.
A new paper suggests that plant- and fish-based diets lessen the chance of developing severe symptoms – but hold off from becoming vegetarian or pescatarian for now.
Why it’s important to pay attention to evolutionary theory when considering population health.
Free doughnuts and lotteries may drive some people to get their COVID-19 vaccine. But for those who are afraid of needles, other interventions may be necessary.
Local institutions and community bonds forged during the turmoil of the 1970s and 1980s helped a vulnerable neighborhood walloped by the pandemic endure.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Though the British prime minister has called on countries to share more doses internationally, the UK may continue to prioritise its domestic rollout.
Accounts of previous epidemics – by Samuel Pepys, Daniel Defoe and Katherine Porter – warn of mistakes that we risk repeating.
Scientists have discovered that SARS-CoV-2 can evade neutralising antibodies by fusing cells.
Picture yourself at the gym. It might be confined, people are huffing and puffing, everyone is moving around. And that’s before you hit the showers and change room.
If you have risk factors around blood clots, heart attack or stroke, this should actually be an impetus to get vaccinated sooner rather than later.
Corporations need to weigh up significant risks against wider benefits.
Despite calls to use them, traditional cost-benefit calculations haven’t featured in the UK’s lockdown decisions.
Denial and deception can be harmful weapons with lethal consequences, neither logic or law is on the side of ‘freedom’ rallies.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Senior Research Fellow in Global Health, University of Southampton
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Public Health, University of Sheffield
-
Associate Professor, Director Cabrini Monash University Department of Nursing Research, Monash University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Medicine, University of East Anglia
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Professor of Mathematics and Statistics, University of Strathclyde
